TGA Approval

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial (11314)

ARTG ID

11314

ARTG Name

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

August 13, 1991

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/30fa992a253a3d444f7d8cd71b79bdfe.pdf

https://medical-cdn.nocode.com/drug_tga/71ddb8c83b7eca25bc2742877469aafe.pdf

Ingredient Name

bupivacaine hydrochloride monohydrate

Empowering clinical research with data-driven insights and AI-powered tools.

Pfizer (Australia) BUPIVACAINE HYDROCHLORIDE 0.25% (50mg/20mL) injection BP vial (11314) - TGA 批准文号 | MedPath